16 : 417422 Esposti D, Mariani M, Demartini G, Lucini V, Fraschini F, Mancia M
Edaravone is being assessed in a Phase 2 clinical trial including 60 participants with a clinical diagnosis of early AD, confirmed by CSF AD biomarkers or amyloid PET (NCT05323812)
People with gallbladder disease or gallstones need careful monitoring
#GLP1 #EmployerHealth #BenefitsStrategy #WorkplaceWellness Debunking 5 GLP-1 Myths in Benefits Planning GLP-1 benefits are not the problem, the problem is about the 5 myths that keep coming up in planning conversations
From Molecule, To Breakthrough WHO WE ARE Breakthrough technologies driving drug discovery ABOUT US Peptides Lab Ireland Your Trusted Source for Research Peptides in Ireland Peptides Lab Ireland provides high-quality research peptides to support scientific work, performance research, and laboratory studies across Ireland